期刊文献+

2型糖尿病患者血清CA19-9水平的变化及其与血糖的关系 被引量:9

下载PDF
导出
摘要 糖尿病是胰腺的慢性炎症性疾病,而高血糖又可对胰岛细胞产生持续刺激[1];同时亦有研究结果提示,糖尿病患者胰腺癌的发病率高于一般人群[2];而血清CA19-9为常用于诊断胰腺癌的一个重要指标,但在一些良性疾病中也可升高,国外已有报道,2型糖尿病与CA19-9相关[3],而国内相关研究较少.本研究旨在探讨中国2型糖尿病患者血清CA19-9水平的变化及其影响因素,现将结果报道如下.
出处 《浙江医学》 CAS 2010年第2期284-286,共3页 Zhejiang Medical Journal
  • 相关文献

参考文献4

二级参考文献28

  • 1徐丽姝,麦韵萍,张瑛华,刘宇斌.血浆K-ras和血清CA19-9联合检测对胰腺癌的诊断作用[J].实用医学杂志,2005,21(23):2645-2646. 被引量:8
  • 2李英梅,夏稻子,马秀丽,刘聪.糖尿病患者胰腺的超声组织定征研究[J].中国医学影像技术,2006,22(3):436-438. 被引量:30
  • 3徐婷,颜勤明,徐丽伟.2型糖尿病患者血清CA19-9浓度的变化及其与血糖的相关性[J].实用医学杂志,2007,23(5):676-677. 被引量:21
  • 4Fisher W E. Diabetes: risk factor for the development of pancreatic canceer or manifestation of the disease [J]? World J Surg, 2001,25(4) : 503-508.
  • 5Petit J M, Vaillant G, Olsson N O, et al. Elevated serum CA19-9 levels in poorly controlled diabetic patients [J]. Gastroenterol Clin Biol, 1994,18(1) : 17-20.
  • 6Nakamura N, Aoji O, YoshiKawa T, et al. Elevated serum CA19-9 levels in poorly controlled diabetic patients [J]. Jpn J Med,1986,25(3 ) : 278-280.
  • 7孙荣武,王鸿利.临床检验结果的评价[M].上海:上海科学技术出版社,2001:451.
  • 8Magnani J L, Nilsson B, Brockhaus M, et al. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N- fucopentaose Ⅱ[ J ]. J Biol Chem,1982,257(23):14365-14369.
  • 9Chang C Y, Huang S P, Chiu H M, et al. Low efficacy of serum levels of CA19-9 in prediction of malignant diseases in asymptomatic population in Taiwan [ J ]. Hepatogastroenterology ,2006,53 ( 6 ) : 1-4.
  • 10Tangkijvanich P, Thong,ngam D, Theamboonlers A, et al. Diagnostic role of serum interleukin 6 and CA19-9 in patients with cholangiocarcinoma[ J]. Hepatogastroenterology ,2004,51 ( 1 ) : 15-19.

共引文献86

同被引文献55

  • 1李胜,赵希义,王春英,仲伟霞,衣龙海.胰腺癌中ERα变异体的表达[J].胰腺病学,2004,4(3):159-162. 被引量:1
  • 2贾雪梅,王惠珠,齐易详,孙骍,盛晓蓉,唐剑云,陈世超,陆云.小鼠实验性糖尿病对胰腺腺泡细胞形态学的影响[J].安徽医科大学学报,1994,29(3):184-186. 被引量:5
  • 3徐丽姝,麦韵萍,张瑛华,刘宇斌.血浆K-ras和血清CA19-9联合检测对胰腺癌的诊断作用[J].实用医学杂志,2005,21(23):2645-2646. 被引量:8
  • 4徐婷,颜勤明,徐丽伟.2型糖尿病患者血清CA19-9浓度的变化及其与血糖的相关性[J].实用医学杂志,2007,23(5):676-677. 被引量:21
  • 5Fisher WE. Diabetes: risk factor for the development of pan- creatic cancer or manifestation of the disease. World J Surg 2001 ;25 (4) : 503-508.
  • 6Petit JM, Vaillant G, Olsson NO, et al. Elevated serum CA199 levels in poorly controlled diabetic patients . Gastroenterol ClinBiol 1994;18(1) : 17-20.
  • 7Nakamura N, Aoji O, YoshiKawa T, et al. Elevated serum CA19 -9 levels in poorly controlled diabetic patients . Jpn J Med 1986;25(3) : 278- 280.
  • 8Madougall C ,Tucker B ,Thompson J et al . A randorruzed study of iron supplementation in patients treated with erythropoietin. Kidney lnt 1993;50:1694 - 1695.
  • 9Steimbergw. The clinical utility of the CA199 tumor - assosi- ated antigen. AmJ Gastroenterology 1990;85 (4) :350 - 355.
  • 10Rntoft TF, Holmes EH, Johnson P, et al. Differential tissue expression of the Lewis blood group antigens: Enzymatic, immunohis- tologic, and immunochemical evidence for Lewis a and b antigen ex- pression in Le ( a - b - ) individuals. Blood 1991 ; 77 ( 6 ) : 1389 - 1396.

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部